NeuroMetrix Reiterates its Review of Strategic Alternatives

Stock Information for NeuroMetrix Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About NeuroMetrix Inc.

NeuroMetrix Reports Q2 2024 Business Highlights and Update on Review of Strategic Options
NeuroMetrix, Inc. Announces Date for Second Quarter 2024 Business Highlights Conference Call
NeuroMetrix Reports Q1 2024 Business Highlights
NeuroMetrix Announces Steps Taken to Enhance Shareholder Value
NeuroMetrix Announces Publication of Study Demonstrating that DPNCheck Accurately Diagnoses Diabetic Peripheral Neuropathy
NeuroMetrix announces that over 2000 patients with fibromyalgia have been prescribed Quell® Fibromyalgia
Echo Lake Capital Issues Top Ten List of Reasons Why Shai Gozani, CEO of Neurometrix Inc., Should Be Fired
Echo Lake Capital Calls for the Liquidation of Neurometrix, Inc.

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.